Detrimental effects of verapamil in patients with primary pulmonary hypertension.

about

Epoprostenol sodium for treatment of pulmonary arterial hypertension.Therapeutic advances in pulmonary arterial hypertension.Pharmacotherapy of chronic pulmonary arterial hypertension: value and limitations. Part I: Primary pulmonary hypertension.

P2860

Q35624220-96D50EF5-406A-4D23-9C73-3D93187D9E2C Q37362631-10314513-FB7B-4286-8BAA-B3205BB32AB2 Q40624806-F448422E-295A-4625-A297-3FA16DC16422

P2860

Detrimental effects of verapamil in patients with primary pulmonary hypertension.

Item

http://www.wikidata.org/entity/Q36751153

description

1984 nî lūn-bûn

@nan

1984年の論文

@ja

1984年論文

@yue

1984年論文

@zh-hant

1984年論文

@zh-hk

1984年論文

@zh-mo

1984年論文

@zh-tw

1984年论文

@wuu

1984年论文

@zh

1984年论文

@zh-cn

name

Detrimental effects of verapamil in patients with primary pulmonary hypertension.

@en

type

Item

label

Detrimental effects of verapamil in patients with primary pulmonary hypertension.

@en

prefLabel

Detrimental effects of verapamil in patients with primary pulmonary hypertension.

@en

P1476

Detrimental effects of verapamil in patients with primary pulmonary hypertension.

@en

P2093

Medina N

http://www.w3.org/2001/XMLSchema#string

Packer M

http://www.w3.org/2001/XMLSchema#string

Wiener I

http://www.w3.org/2001/XMLSchema#string

Yushak M

http://www.w3.org/2001/XMLSchema#string

P2860

Cerebral arterial spasm--a controlled trial of nimodipine in patients with subarachnoid hemorrhage.

Recent studies in primary pulmonary hypertension, including pharmacodynamic observations on pulmonary vascular resistance

Diazoxide in treatment of primary pulmonary hypertension.

Primary pulmonary hypertension: effects of nifedipine.

Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle.

Effects of verapamil and aspirin on experimental chronic hypoxic pulmonary hypertension and right ventricular hypertrophy in rats.

Comparative pharmacology of calcium antagonists: nifedipine, verapamil and diltiazem.

Verapamil and pulmonary hypertension.

Nifedipine therapy in angina pectoris: evaluation of safety and side effects.

Treatment of primary pulmonary hypertension with nifedipine. A hemodynamic and scintigraphic evaluation.

P304

106-111

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/HRT.52.1.106

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1984-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

16456412

http://www.w3.org/2001/XMLSchema#string

P698

6743418

http://www.w3.org/2001/XMLSchema#string

P932

481593

http://www.w3.org/2001/XMLSchema#string

Detrimental effects of verapamil in patients with primary pulmonary hypertension.

about

P2860

P2860

Detrimental effects of verapamil in patients with primary pulmonary hypertension.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932